Alexander K. Arrow bought $6,480 of PTIX
Chief Financial Officer at Protagenic Therapeutics, Inc.\new. 8,000 shares at an average of $0.81, traded Oct 12, 2023, filed Oct 13, 2023.
Score components
- +22RoleCFO
- 0Trade size$6k at market
- +6Relative to holdingsHoldings up 21%
- +18Price context0% above the 52-week low; 72% below the 52-week high
- 0ClusterNo other insider buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -4.6%, 3m +0.1%, 6m +71.6%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001493152-23-037136, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Oct 12, 2023 | POpen-market purchase PTIX Common Stock | +8,000 | $0.81 | $6,480 | 45,815 | Oct 13, 2023 |
Related signals
Other insiders at Protagenic Therapeutics, Inc.\new and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 31Weak | PTIXbuy Protagenic Therapeutics, Inc.\new | Garo H Armen EXEC. CHAIR & PRINCIPAL OFF | $13k 20,000 shares | +37% | |
| 28Weak | PTIXbuy Protagenic Therapeutics, Inc.\new | Garo H Armen EXEC. CHAIR & PRINCIPAL OFF | $945 2,700 shares | +8% | |
| 31Weak | PTIXbuy Protagenic Therapeutics, Inc.\new | Garo H Armen EXEC. CHAIR & PRINCIPAL OFF | $9,811 16,634 shares | +45% | |
| 28Weak | PTIXbuy Protagenic Therapeutics, Inc.\new | Garo H Armen EXEC. CHAIR & PRINCIPAL OFF | $710 2,220 shares | +7% | |
| 25Weak | PTIXbuy Protagenic Therapeutics, Inc.\new | Garo H Armen EXEC. CHAIR & PRINCIPAL OFF | $151 685 shares | +2% | |
| 28Weak | PTIXbuy Protagenic Therapeutics, Inc.\new | Garo H Armen EXEC. CHAIR & PRINCIPAL OFF | $1,294 5,000 shares | +19% | |
| 28Weak | PTIXbuy Protagenic Therapeutics, Inc.\new | Garo H Armen EXEC. CHAIR & PRINCIPAL OFF. | $4,806 26,291 shares | - |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.